Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 4/20 | 0.76 |
| ▸ | CNR1 | P21554 | 16/20 | 0.63 |
| ▸ | HTR2C | P28335 | 3/20 | 0.57 |
| ▸ | CNR2 | P34972 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6200547 | 0.91 | HTR2A (0.70) | HTR2ACNR1HTR2CCNR2 | |
| SCHEMBL6201540 | 0.90 | HTR2A (0.68) | HTR2ACNR1HTR2CCNR2 | |
| SCHEMBL6201643 | 0.88 | HTR2A (0.79) | HTR2ACNR1HTR2CCNR2 | |
| SCHEMBL6222352 | 0.88 | HTR2A (0.74) | HTR2ACNR1HTR2CCNR2 | |
| SCHEMBL6197082 | 0.87 | CNR1 (0.71) | HTR2ACNR1HTR2CCNR2 | |
| SCHEMBL6201578 | 0.87 | HTR2A (0.67) | HTR2ACNR1HTR2CCNR2 | |
| SCHEMBL6201624 | 0.86 | HTR2A (1.00) | HTR2ACNR1HTR2CCNR2 | |
| SCHEMBL6196740 | 0.86 | HTR2A (0.76) | HTR2ACNR1HTR2CCNR2 | |
| SCHEMBL6202409 | 0.85 | HTR2A (0.74) | HTR2ACNR1HTR2CCNR2 | |
| SCHEMBL6197665 | 0.84 | HTR2A (0.72) | HTR2ACNR1HTR2CCNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1509505-A2 | SMALL MOLECULE MODULATORS OF THE 5−HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2005-03-02 | — | — | EP | claimed |
| WO-2003062206-A2 | SMALL MOLECULE MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2003-07-31 | — | — | WO | claimed |